MiNK Therapeutics, Inc.
- Last sale
- Nov 12, 2026 · -10.06%
- Market cap
- $49.82M
- 5.13M shares
- Filings
- 267
Q3 2026
—Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY23 yoy
Q3 2026N/M FY25 yoy
Q3 2026+191.9% FY25 yoy
- $49.82M
- —
- —
- —
- —
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
No annual history for this metric yet.
| Period | Ended | Value | Kind | Source trail |
|---|
Biological products, except diagnostic substances
MiNK Therapeutics, Inc. is the 124th largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836
CompanyRevenueGrowthNet marginMarket cap
SGMOQSangamo Therapeutics, Inc$39.6M31.6%310.8%$58.0MCRDFCardiff Oncology, Inc.$593.0K13.2%7,732.0%$56.8MAPTNAdaptin Bio, Inc.———$55.4MELOXEloxx Pharmaceuticals, Inc.$0.0100.0%—$51.4M
INKTMiNK Therapeutics, Inc. (this company)———$49.8M
TILInstil Bio, Inc.———$47.1MIMAImageneBio, Inc.$800.0K77.1%5,668.6%$45.0MIRLAIRulya Therapeutics Inc.———$40.8MCRBUCaribou Biosciences, Inc.$11.2M11.7%1,327.4%$40.8MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
MiNK Therapeutics, Inc. · CIK 1840229 · Engraved from SEC EDGAR